13 ASCO Stocks Presenting New Clinical Data

BOSTON (TheStreet) -- The American Society of Clinical Oncology (ASCO) posted thousands of cancer drug research abstracts to its web site Thursday night, in advance of its closely watched annual meeting.

The ASCO annual meeting runs June 4-8 and brings together cancer drug researchers from all over the world to discuss and present new clinical data aimed at treating -- and maybe one day curing -- cancer.

The ASCO annual meeting also attracts investors in almost equal numbers because treating cancer is big business. Wall Street pays close attention because the ASCO meeting moves biotech and drug stocks, often well before the ASCO confab even gets started.

Wall Street's focus on the ASCO annual meeting kicked into another gear Thursday night with the release of the research abstracts. Previously, I assembled a list of biotech and drug stocks that will be presenting new clinical data at this year's ASCO meeting. I've now updated this list with information and data taken from the newly released research abstracts.

> > Bull or Bear? Vote in Our Poll

Flip through the list of ASCO stocks on the following pages: